Overview / Abstract: |
Systemic mastocytosis (SM) is a group of rare disorders characterized by the accumulation of mast cells in internal tissues and organs. The pathogenesis of SM is linked to a characteristic exon 17 D816V mutation of the KIT gene. Systemic mastocytosis with associated hematologic neoplasms (SM-AHN) is an advanced subtype of SM that is associated with a shortened median survival time. Recent advances in the SM therapeutic landscape have led to the development of KIT-targeted treatment options; however, the heterogeneous clinical presentation and complex nature of SM-AHN can delay diagnosis and, therefore, treatment. This engaging educational activity provides concise and practical information about SM-AHN in a coffee-talk style format, examining the pathogenesis and challenges in diagnosis, as well as the factors that influence prognosis and therapeutic decision-making in patients with SM-AHN. |
Expiration |
Oct 02, 2024 |
Format |
Online, Webinar / Webcast / Video, Workbook |
Credits / Hours |
0.75 |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Andrew Kuykendall, MD Tracy I. George, MD |
Sponsors / Supporters / Grant Providers |
This activity is provided by Integritas Communications. (ACCME Credit) This activity is jointly provided by Global Education Group and Integritas Communications. (ANCC & ACPE Credit) This activity is supported by an educational grant from Blueprint Medicines. |
Keywords / Search Terms |
Integritas Communications Systemic mastocytosis, SM-AHN Free CE CME |